Your browser doesn't support javascript.
loading
Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial.
Terada-Hirashima, Junko; Suzuki, Manabu; Tsujimoto, Yoshie; Hamamoto, Yoichiro; Uemura, Yukari; Tsushima, Kenji; Inoue, Hideki; Komatsu, Shigeru; Saito, Zenya; Tsuzuki, Ryuta; Okamoto, Masaki; To, Yasuo; Moriya, Kyoji; Yoshizawa, Sadako; Tanaka, Masahide; Muto, Toshitaka; Mikami, Ayako; Takasaki, Jin; Izumi, Shinyu; Ohmagari, Norio; Hojo, Masayuki; Sugiura, Wataru; Sugiyama, Haruhito.
  • Terada-Hirashima J; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Suzuki M; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Tsujimoto Y; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Hamamoto Y; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Uemura Y; Department of Respiratory Medicine, National Hospital Organization Nishisaitama-Chuo National Hospital, Saitama, Japan.
  • Tsushima K; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Inoue H; International University of Health and Welfare, Narita Hospital, Chiba, Japan.
  • Komatsu S; Respiratory/Allergy Internal Medicine, Showa University Hospital, Tokyo, Japan.
  • Saito Z; Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
  • Tsuzuki R; Respiratory Medicine, Atsugi City Hospital, Kanagawa, Japan.
  • Okamoto M; Allergy and Respiratory Medicine, The Fraternity Memorial Hospital, Tokyo, Japan.
  • To Y; Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Moriya K; Respiratory Diseases Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
  • Yoshizawa S; Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan.
  • Tanaka M; Department of Clinical Laboratory/Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo Japan.
  • Muto T; Respiratory Medicine, National Hospital Organization Higashisaga Hospital, Saga, Japan.
  • Mikami A; Hematology, National Hospital Organization Kokura Medical Center, Fukuoka, Japan.
  • Takasaki J; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Izumi S; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Hojo M; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Sugiura W; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Sugiyama H; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Drug Discov Ther ; 16(5): 225-232, 2022 Nov 20.
Article en En | MEDLINE | ID: mdl-36288939
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pregnenodionas / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pregnenodionas / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article